APO Research

APO RESEARCH · REPORT

Alfuzosin

Selected research

Market Structure

Global Alfuzosin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Alfuzosin market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Alfuzosin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Alfuzosin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Alfuzosin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Alfuzosin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Alfuzosin include Teva, Sun Pharma, Mylan, Wockhardt, Unichem Laboratories, Torrent Pharmaceuticals, Cipla, Aurobindo and Apotex, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Alfuzosin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Alfuzosin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Alfuzosin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Alfuzosin market size, projected growth trends, production technologies, key applications, and end-use industries.

Alfuzosin Segment by Company

Teva

Sun Pharma

Mylan

Wockhardt

Unichem Laboratories

Torrent Pharmaceuticals

Cipla

Aurobindo

Apotex

Alfuzosin Segment by Type

2.5mg Tablets

10mg Tablets

Alfuzosin Segment by Application

Hospital

Drug store

Alfuzosin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alfuzosin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Alfuzosin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alfuzosin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Alfuzosin market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Alfuzosin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Alfuzosin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Alfuzosin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Alfuzosin Industry Trends Table 2. Alfuzosin Industry Drivers Table 3. Alfuzosin Industry Opportunities and Challenges Table 4. Alfuzosin Industry Restraints Table 5. Global Alfuzosin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Alfuzosin Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Alfuzosin Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Alfuzosin Sales Market Share by Manufacturers Table 9. Global Alfuzosin Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Alfuzosin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Alfuzosin Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Alfuzosin Manufacturers, Product Type & Application Table 13. Global Alfuzosin Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Alfuzosin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 2.5mg Tablets Table 17. Major Manufacturers of 10mg Tablets Table 18. Global Alfuzosin Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Alfuzosin Sales by Type (2021-2026) & (k units) Table 20. Global Alfuzosin Sales by Type (2027-2032) & (k units) Table 21. Global Alfuzosin Sales Market Share by Type (2021-2026) Table 22. Global Alfuzosin Sales Market Share by Type (2027-2032) Table 23. Global Alfuzosin Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Alfuzosin Revenue by Type (2021-2026) & (k units) Table 25. Global Alfuzosin Revenue by Type (2027-2032) & (k units) Table 26. Global Alfuzosin Revenue Market Share by Type (2021-2026) Table 27. Global Alfuzosin Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Drug store Table 30. Global Alfuzosin Sales by Application 2021 VS 2025 VS 2032 (k units) Table 31. Global Alfuzosin Sales by Application (2021-2026) & (k units) Table 32. Global Alfuzosin Sales by Application (2027-2032) & (k units) Table 33. Global Alfuzosin Sales Market Share by Application (2021-2026) Table 34. Global Alfuzosin Sales Market Share by Application (2027-2032) Table 35. Global Alfuzosin Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Alfuzosin Revenue by Application (2021-2026) & (k units) Table 37. Global Alfuzosin Revenue by Application (2027-2032) & (k units) Table 38. Global Alfuzosin Revenue Market Share by Application (2021-2026) Table 39. Global Alfuzosin Revenue Market Share by Application (2027-2032) Table 40. Global Alfuzosin Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 41. Global Alfuzosin Sales by Region (2021-2026) & (k units) Table 42. Global Alfuzosin Sales Market Share by Region (2021-2026) Table 43. Global Alfuzosin Sales Forecasted by Region (2027-2032) & (k units) Table 44. Global Alfuzosin Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Alfuzosin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 46. North America Alfuzosin Sales by Country (2021-2026) & (k units) Table 47. North America Alfuzosin Sales by Country (2027-2032) & (k units) Table 48. Europe Alfuzosin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. Europe Alfuzosin Sales by Country (2021-2026) & (k units) Table 50. Europe Alfuzosin Sales by Country (2027-2032) & (k units) Table 51. Asia Pacific Alfuzosin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Asia Pacific Alfuzosin Sales by Country (2021-2026) & (k units) Table 53. Asia Pacific Alfuzosin Sales by Country (2027-2032) & (k units) Table 54. South America, Middle East and Africa Alfuzosin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. South America, Middle East and Africa Alfuzosin Sales by Country (2021-2026) & (k units) Table 56. South America, Middle East and Africa Alfuzosin Sales by Country (2027-2032) & (k units) Table 57. Global Alfuzosin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Alfuzosin Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Alfuzosin Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Alfuzosin Revenue Market Share by Region (2021-2026) Table 61. Global Alfuzosin Revenue Market Share by Region (2027-2032) Table 62. Teva Company Information Table 63. Teva Business Overview Table 64. Teva Alfuzosin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Teva Alfuzosin Product Portfolio Table 66. Teva Recent Development Table 67. Sun Pharma Company Information Table 68. Sun Pharma Business Overview Table 69. Sun Pharma Alfuzosin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Sun Pharma Alfuzosin Product Portfolio Table 71. Sun Pharma Recent Development Table 72. Mylan Company Information Table 73. Mylan Business Overview Table 74. Mylan Alfuzosin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Mylan Alfuzosin Product Portfolio Table 76. Mylan Recent Development Table 77. Wockhardt Company Information Table 78. Wockhardt Business Overview Table 79. Wockhardt Alfuzosin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Wockhardt Alfuzosin Product Portfolio Table 81. Wockhardt Recent Development Table 82. Unichem Laboratories Company Information Table 83. Unichem Laboratories Business Overview Table 84. Unichem Laboratories Alfuzosin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Unichem Laboratories Alfuzosin Product Portfolio Table 86. Unichem Laboratories Recent Development Table 87. Torrent Pharmaceuticals Company Information Table 88. Torrent Pharmaceuticals Business Overview Table 89. Torrent Pharmaceuticals Alfuzosin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Torrent Pharmaceuticals Alfuzosin Product Portfolio Table 91. Torrent Pharmaceuticals Recent Development Table 92. Cipla Company Information Table 93. Cipla Business Overview Table 94. Cipla Alfuzosin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Cipla Alfuzosin Product Portfolio Table 96. Cipla Recent Development Table 97. Aurobindo Company Information Table 98. Aurobindo Business Overview Table 99. Aurobindo Alfuzosin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Aurobindo Alfuzosin Product Portfolio Table 101. Aurobindo Recent Development Table 102. Apotex Company Information Table 103. Apotex Business Overview Table 104. Apotex Alfuzosin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Apotex Alfuzosin Product Portfolio Table 106. Apotex Recent Development Table 107. Key Raw Materials Table 108. Raw Materials Key Suppliers Table 109. Alfuzosin Distributors List Table 110. Alfuzosin Customers List Table 111. Research Programs/Design for This Report Table 112. Authors List of This Report Table 113. Secondary Sources Table 114. Primary Sources List of Figures Figure 1. Alfuzosin Product Image Figure 2. Global Alfuzosin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Alfuzosin Market Size (2021-2032) & (US$ Million) Figure 4. Global Alfuzosin Sales (2021-2032) & (k units) Figure 5. Global Alfuzosin Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Alfuzosin Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 2.5mg Tablets Image Figure 9. 10mg Tablets Image Figure 10. Global Alfuzosin Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Alfuzosin Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Alfuzosin Sales Market Share by Type (2021-2032) Figure 13. Global Alfuzosin Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Alfuzosin Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Alfuzosin Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Drug store Image Figure 18. Global Alfuzosin Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 19. Global Alfuzosin Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Alfuzosin Sales Market Share by Application (2021-2032) Figure 21. Global Alfuzosin Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Alfuzosin Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Alfuzosin Revenue Market Share by Application (2021-2032) Figure 24. North America Alfuzosin Sales and Growth Rate (2021-2032) & (k units) Figure 25. North America Alfuzosin Sales Market Share by Country (2021-2032) Figure 26. U.S. Alfuzosin Sales and Growth Rate (2021-2032) & (k units) Figure 27. Canada Alfuzosin Sales and Growth Rate (2021-2032) & (k units) Figure 28. Mexico Alfuzosin Sales and Growth Rate (2021-2032) & (k units) Figure 29. Europe Alfuzosin Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Alfuzosin Sales Market Share by Country (2021-2032) Figure 31. Germany Alfuzosin Sales and Growth Rate (2021-2032) & (k units) Figure 32. France Alfuzosin Sales and Growth Rate (2021-2032) & (k units) Figure 33. U.K. Alfuzosin Sales and Growth Rate (2021-2032) & (k units) Figure 34. Italy Alfuzosin Sales and Growth Rate (2021-2032) & (k units) Figure 35. Netherlands Alfuzosin Sales and Growth Rate (2021-2032) & (k units) Figure 36. Asia Pacific Alfuzosin Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Alfuzosin Sales Market Share by Country (2021-2032) Figure 38. China Alfuzosin Sales and Growth Rate (2021-2032) & (k units) Figure 39. Japan Alfuzosin Sales and Growth Rate (2021-2032) & (k units) Figure 40. South Korea Alfuzosin Sales and Growth Rate (2021-2032) & (k units) Figure 41. Southeast Asia Alfuzosin Sales and Growth Rate (2021-2032) & (k units) Figure 42. India Alfuzosin Sales and Growth Rate (2021-2032) & (k units) Figure 43. Australia Alfuzosin Sales and Growth Rate (2021-2032) & (k units) Figure 44. South America, Middle East and Africa Alfuzosin Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Alfuzosin Sales Market Share by Country (2021-2032) Figure 46. Brazil Alfuzosin Sales and Growth Rate (2021-2032) & (k units) Figure 47. South Africa Alfuzosin Sales and Growth Rate (2021-2032) & (k units) Figure 48. Saudi Arabia Alfuzosin Sales and Growth Rate (2021-2032) & (k units) Figure 49. Turkey Alfuzosin Sales and Growth Rate (2021-2032) & (k units) Figure 50. Argentina Alfuzosin Sales and Growth Rate (2021-2032) & (k units) Figure 51. UAE Alfuzosin Sales and Growth Rate (2021-2032) & (k units) Figure 52. Egypt Alfuzosin Sales and Growth Rate (2021-2032) & (k units) Figure 53. Chile Alfuzosin Sales and Growth Rate (2021-2032) & (k units) Figure 54. Global Alfuzosin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Alfuzosin Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Alfuzosin Revenue (2021-2032) & (US$ Million) Figure 57. North America Alfuzosin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Alfuzosin Revenue (2021-2032) & (US$ Million) Figure 59. Europe Alfuzosin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Alfuzosin Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Alfuzosin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Alfuzosin Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Alfuzosin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Alfuzosin Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Alfuzosin Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 2.5mg Tablets
  • 10mg Tablets
Applications
  • Hospital
  • Drug store
Companies covered
  • Teva
  • Sun Pharma
  • Mylan
  • Wockhardt
  • Unichem Laboratories
  • Torrent Pharmaceuticals
  • Cipla
  • Aurobindo
  • Apotex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Alfuzosin Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Alfuzosin Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Alfuzosin Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Alfuzosin Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Alfuzosin Market Dynamics
  1. 2.1 Alfuzosin Industry Trends
  2. 2.2 Alfuzosin Industry Drivers
  3. 2.3 Alfuzosin Industry Opportunities and Challenges
  4. 2.4 Alfuzosin Industry Restraints
3 Alfuzosin Market by Manufacturers
  1. 3.1 Global Alfuzosin Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Alfuzosin Sales by Manufacturers (2021-2026)
  3. 3.3 Global Alfuzosin Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Alfuzosin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Alfuzosin Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Alfuzosin Manufacturers, Product Type & Application
  7. 3.7 Global Alfuzosin Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Alfuzosin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Alfuzosin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Alfuzosin Tier 1, Tier 2, and Tier 3
4 Alfuzosin Market by Type
  1. 4.1 Alfuzosin Type Introduction
  2. 4.1.1 2.5mg Tablets
  3. 4.1.2 10mg Tablets
  4. 4.2 Global Alfuzosin Sales by Type
  5. 4.2.1 Global Alfuzosin Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Alfuzosin Sales by Type (2021-2032)
  7. 4.2.3 Global Alfuzosin Sales Market Share by Type (2021-2032)
  8. 4.3 Global Alfuzosin Revenue by Type
  9. 4.3.1 Global Alfuzosin Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Alfuzosin Revenue by Type (2021-2032)
  11. 4.3.3 Global Alfuzosin Revenue Market Share by Type (2021-2032)
5 Alfuzosin Market by Application
  1. 5.1 Alfuzosin Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Drug store
  4. 5.2 Global Alfuzosin Sales by Application
  5. 5.2.1 Global Alfuzosin Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Alfuzosin Sales by Application (2021-2032)
  7. 5.2.3 Global Alfuzosin Sales Market Share by Application (2021-2032)
  8. 5.3 Global Alfuzosin Revenue by Application
  9. 5.3.1 Global Alfuzosin Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Alfuzosin Revenue by Application (2021-2032)
  11. 5.3.3 Global Alfuzosin Revenue Market Share by Application (2021-2032)
6 Global Alfuzosin Sales by Region
  1. 6.1 Global Alfuzosin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Alfuzosin Sales by Region (2021-2032)
  3. 6.2.1 Global Alfuzosin Sales by Region (2021-2026)
  4. 6.2.2 Global Alfuzosin Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Alfuzosin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Alfuzosin Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Alfuzosin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Alfuzosin Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Alfuzosin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Alfuzosin Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Alfuzosin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Alfuzosin Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Alfuzosin Revenue by Region
  1. 7.1 Global Alfuzosin Revenue by Region
  2. 7.1.1 Global Alfuzosin Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Alfuzosin Revenue by Region (2021-2026)
  4. 7.1.3 Global Alfuzosin Revenue by Region (2027-2032)
  5. 7.1.4 Global Alfuzosin Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Alfuzosin Revenue (2021-2032)
  8. 7.2.2 North America Alfuzosin Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Alfuzosin Revenue (2021-2032)
  11. 7.3.2 Europe Alfuzosin Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Alfuzosin Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Alfuzosin Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Alfuzosin Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Alfuzosin Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Alfuzosin Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Alfuzosin Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Sun Pharma
  8. 8.2.1 Sun Pharma Company Information
  9. 8.2.2 Sun Pharma Business Overview
  10. 8.2.3 Sun Pharma Alfuzosin Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sun Pharma Alfuzosin Product Portfolio
  12. 8.2.5 Sun Pharma Recent Developments
  13. 8.3 Mylan
  14. 8.3.1 Mylan Company Information
  15. 8.3.2 Mylan Business Overview
  16. 8.3.3 Mylan Alfuzosin Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Mylan Alfuzosin Product Portfolio
  18. 8.3.5 Mylan Recent Developments
  19. 8.4 Wockhardt
  20. 8.4.1 Wockhardt Company Information
  21. 8.4.2 Wockhardt Business Overview
  22. 8.4.3 Wockhardt Alfuzosin Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Wockhardt Alfuzosin Product Portfolio
  24. 8.4.5 Wockhardt Recent Developments
  25. 8.5 Unichem Laboratories
  26. 8.5.1 Unichem Laboratories Company Information
  27. 8.5.2 Unichem Laboratories Business Overview
  28. 8.5.3 Unichem Laboratories Alfuzosin Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Unichem Laboratories Alfuzosin Product Portfolio
  30. 8.5.5 Unichem Laboratories Recent Developments
  31. 8.6 Torrent Pharmaceuticals
  32. 8.6.1 Torrent Pharmaceuticals Company Information
  33. 8.6.2 Torrent Pharmaceuticals Business Overview
  34. 8.6.3 Torrent Pharmaceuticals Alfuzosin Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Torrent Pharmaceuticals Alfuzosin Product Portfolio
  36. 8.6.5 Torrent Pharmaceuticals Recent Developments
  37. 8.7 Cipla
  38. 8.7.1 Cipla Company Information
  39. 8.7.2 Cipla Business Overview
  40. 8.7.3 Cipla Alfuzosin Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Cipla Alfuzosin Product Portfolio
  42. 8.7.5 Cipla Recent Developments
  43. 8.8 Aurobindo
  44. 8.8.1 Aurobindo Company Information
  45. 8.8.2 Aurobindo Business Overview
  46. 8.8.3 Aurobindo Alfuzosin Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Aurobindo Alfuzosin Product Portfolio
  48. 8.8.5 Aurobindo Recent Developments
  49. 8.9 Apotex
  50. 8.9.1 Apotex Company Information
  51. 8.9.2 Apotex Business Overview
  52. 8.9.3 Apotex Alfuzosin Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Apotex Alfuzosin Product Portfolio
  54. 8.9.5 Apotex Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Alfuzosin Value Chain Analysis
  2. 9.1.1 Alfuzosin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Alfuzosin Production Mode & Process
  6. 9.2 Alfuzosin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Alfuzosin Distributors
  9. 9.2.3 Alfuzosin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research